Home/Pipeline/Recombinant Human Follicle-Stimulating Hormone (rFSH)

Recombinant Human Follicle-Stimulating Hormone (rFSH)

Infertility

ApprovedCommercial

Key Facts

Indication
Infertility
Phase
Approved
Status
Commercial
Company

About Changchun High-Tech Industry

Changchun High-Tech is a prominent, revenue-generating biopharmaceutical enterprise in China, primarily known for its vaccine business. Its strategic position is anchored by its controlling stake in Changchun BCHT Biotechnology, a critical supplier of the Varicella vaccine in the domestic market. The company leverages this established commercial foundation to invest in and develop a broader pipeline of biological products, including monoclonal antibodies and other innovative therapeutics. As a publicly listed entity, it operates with a diversified business model that also includes investments in real estate and other industries.

View full company profile